MVM Life Science Partners, based in Massachusetts, leads Series A and B rounds with checks of $10M to over $30M in healthtech and life sciences, backing firms like Sangamo Therapeutics.
3 people on the investing team, 3 of them partners who can make the call. Partners are listed first.

Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
MVM Life Science Partners reports entry at series a, series b.
MVM Life Science Partners reports checks of $10M to $30M+.
Yes. MVM Life Science Partners says it can lead.
Eric Bednarski (Managing Partner), Kyle Dempsey (Partner), Thomas Casdagli (Partner).
No recent activity since September 2026.
Work at MVM Life Science Partners? Claim or correct this profile.